Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4156073
[patent_doc_number] => 06124431
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'Peptide derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/039426
[patent_app_country] => US
[patent_app_date] => 1998-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6098
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124431.pdf
[firstpage_image] =>[orig_patent_app_number] => 039426
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/039426 | Peptide derivatives | Mar 15, 1998 | Issued |
Array
(
[id] => 4071999
[patent_doc_number] => 06069129
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Elastin derived composition and method of using same'
[patent_app_type] => 1
[patent_app_number] => 9/039308
[patent_app_country] => US
[patent_app_date] => 1998-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 7664
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/069/06069129.pdf
[firstpage_image] =>[orig_patent_app_number] => 039308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/039308 | Elastin derived composition and method of using same | Mar 12, 1998 | Issued |
Array
(
[id] => 4183919
[patent_doc_number] => 06150332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Method and composition for lowering low density lipoprotein cholesterol'
[patent_app_type] => 1
[patent_app_number] => 9/038935
[patent_app_country] => US
[patent_app_date] => 1998-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3955
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150332.pdf
[firstpage_image] =>[orig_patent_app_number] => 038935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/038935 | Method and composition for lowering low density lipoprotein cholesterol | Mar 11, 1998 | Issued |
09/038432 | DERIVATIVES OF GLP-1 ANALOGS | Mar 10, 1998 | Abandoned |
Array
(
[id] => 4410177
[patent_doc_number] => 06228840
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Melanocortin receptor antagonists and modulations of melanocortin receptor activity'
[patent_app_type] => 1
[patent_app_number] => 9/031902
[patent_app_country] => US
[patent_app_date] => 1998-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7683
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228840.pdf
[firstpage_image] =>[orig_patent_app_number] => 031902
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/031902 | Melanocortin receptor antagonists and modulations of melanocortin receptor activity | Feb 26, 1998 | Issued |
Array
(
[id] => 4156019
[patent_doc_number] => 06103699
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Peptide, a method for its preparation and a pharmaceutical composition containing the peptide'
[patent_app_type] => 1
[patent_app_number] => 9/032550
[patent_app_country] => US
[patent_app_date] => 1998-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9421
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103699.pdf
[firstpage_image] =>[orig_patent_app_number] => 032550
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/032550 | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide | Feb 25, 1998 | Issued |
09/031122 | ANTIBACTERIAL DRUGS, METHODS FOR THEIR DESIGN AND METHODS FOR THEIR USE | Feb 25, 1998 | Abandoned |
08/952972 | PEPTIDE FRAGMENTS OF TISSUE FACTOR AND THEIR USE FOR TREATMENT AND PREVENTION OF CLOTTING DISORDERS | Feb 23, 1998 | Abandoned |
Array
(
[id] => 4059395
[patent_doc_number] => 06007804
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'IL-6 as serum uric acid decreasing compound'
[patent_app_type] => 1
[patent_app_number] => 9/027618
[patent_app_country] => US
[patent_app_date] => 1998-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2077
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/007/06007804.pdf
[firstpage_image] =>[orig_patent_app_number] => 027618
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/027618 | IL-6 as serum uric acid decreasing compound | Feb 22, 1998 | Issued |
Array
(
[id] => 3945957
[patent_doc_number] => 05998376
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Substance P treatment for immunostimulation'
[patent_app_type] => 1
[patent_app_number] => 9/028003
[patent_app_country] => US
[patent_app_date] => 1998-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 6671
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998376.pdf
[firstpage_image] =>[orig_patent_app_number] => 028003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/028003 | Substance P treatment for immunostimulation | Feb 22, 1998 | Issued |
Array
(
[id] => 4267865
[patent_doc_number] => 06245502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Target system'
[patent_app_type] => 1
[patent_app_number] => 9/026904
[patent_app_country] => US
[patent_app_date] => 1998-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10383
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245502.pdf
[firstpage_image] =>[orig_patent_app_number] => 026904
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/026904 | Target system | Feb 18, 1998 | Issued |
Array
(
[id] => 4088990
[patent_doc_number] => 06133233
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Peptide modulation of reperfusion injury'
[patent_app_type] => 1
[patent_app_number] => 9/024975
[patent_app_country] => US
[patent_app_date] => 1998-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5360
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133233.pdf
[firstpage_image] =>[orig_patent_app_number] => 024975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/024975 | Peptide modulation of reperfusion injury | Feb 15, 1998 | Issued |
Array
(
[id] => 4207915
[patent_doc_number] => 06028056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Pharmaceutical compositions for imaging and treating thrombi'
[patent_app_type] => 1
[patent_app_number] => 9/020086
[patent_app_country] => US
[patent_app_date] => 1998-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3644
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/028/06028056.pdf
[firstpage_image] =>[orig_patent_app_number] => 020086
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/020086 | Pharmaceutical compositions for imaging and treating thrombi | Feb 5, 1998 | Issued |
09/016346 | METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | Jan 29, 1998 | Abandoned |
Array
(
[id] => 3949507
[patent_doc_number] => 05955431
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Mast cell protease peptide inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/016366
[patent_app_country] => US
[patent_app_date] => 1998-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20599
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955431.pdf
[firstpage_image] =>[orig_patent_app_number] => 016366
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/016366 | Mast cell protease peptide inhibitors | Jan 29, 1998 | Issued |
Array
(
[id] => 4373262
[patent_doc_number] => 06288216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Process for isolating a protein composition from a muscle source and protein composition'
[patent_app_type] => 1
[patent_app_number] => 9/015760
[patent_app_country] => US
[patent_app_date] => 1998-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10108
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288216.pdf
[firstpage_image] =>[orig_patent_app_number] => 015760
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/015760 | Process for isolating a protein composition from a muscle source and protein composition | Jan 28, 1998 | Issued |
09/015394 | ABSORBABLE MICROPARTICLES | Jan 28, 1998 | Abandoned |
08/983632 | USE OF NEURONAL CALCIUM CHANNEL BLOCKERS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSES, SCHIZOPHRENIA, AND COCAINE OR AMPHETAMINE ADDICTION | Jan 22, 1998 | Abandoned |
08/983583 | METHIONINE, PENICILLAMINE AND CYSTEINE-ANALOGUE CONTAINING PEPTIDES HAVING IMMUNOMODULATING ACTIVITY | Jan 21, 1998 | Abandoned |
09/000087 | HETERODIMER PEPTIDES WITH IMMUNOMODULATORY EFFECT | Jan 21, 1998 | Abandoned |